Everpure, Inc. Income Taxes Disclosure
| Fiscal Year Ended | |||||||||||||||||
| 2024 | 2025 | 2026 | |||||||||||||||
| Domestic | $ | (2,565) | $ | 32,566 | $ | 84,344 | |||||||||||
| International | 93,151 | 115,268 | 139,940 | ||||||||||||||
| Total | $ | 90,586 | $ | 147,834 | $ | 224,284 | |||||||||||
| Fiscal Year Ended | |||||||||||||||||
| 2024 | 2025 | 2026 | |||||||||||||||
| Current: | |||||||||||||||||
| Federal | $ | 2,407 | $ | 268 | $ | 637 | |||||||||||
| State | 9,678 | 5,474 | 3,459 | ||||||||||||||
| Foreign | 15,239 | 26,631 | 24,152 | ||||||||||||||
| Total | $ | 27,324 | $ | 32,373 | $ | 28,248 | |||||||||||
| Deferred: | |||||||||||||||||
| Foreign | $ | 1,951 | $ | 8,722 | $ | 7,855 | |||||||||||
| Provision for income taxes | $ | 29,275 | $ | 41,095 | $ | 36,103 | |||||||||||
| Fiscal Year Ended | |||||||||||
| 2024 | 2025 | ||||||||||
| Tax at federal statutory rate | $ | 19,023 | $ | 31,045 | |||||||
| State tax, net of federal benefit | 7,559 | 3,966 | |||||||||
| Stock-based compensation expense | (21,779) | (50,981) | |||||||||
| Research and development tax credits | (19,033) | (36,379) | |||||||||
| U.S. taxes on foreign income | 10,956 | 12,701 | |||||||||
Foreign-derived intangible income deduction | (8,706) | (2,882) | |||||||||
| Foreign rate differential | (5,861) | 4,327 | |||||||||
| Withholding tax | 3,490 | 6,820 | |||||||||
| Change in valuation allowance | 37,529 | 69,432 | |||||||||
| Non-deductible expenses | 2,943 | 2,646 | |||||||||
| Other | 3,154 | 400 | |||||||||
| Provision for income taxes | $ | 29,275 | $ | 41,095 | |||||||
Fiscal Year Ended 2026 | |||||||||||
| Amount | Percent | ||||||||||
| U.S. federal statutory tax rate | $ | 47,100 | 21.0 | % | |||||||
State and local income taxes, net of federal benefit (1) | 2,714 | 1.2 | |||||||||
| Foreign tax effects: | |||||||||||
| Ireland | |||||||||||
| Statutory rate differential | (8,158) | (3.6) | |||||||||
| Interest income | 6,432 | 2.9 | |||||||||
| Other | (249) | (0.1) | |||||||||
| Brazil | 2,496 | 1.1 | |||||||||
| Czech Republic | |||||||||||
| Research and development tax credits | (5,630) | (2.5) | |||||||||
| Other | (821) | (0.4) | |||||||||
| United Kingdom | |||||||||||
| Intercompany revenue true up | 2,560 | 1.1 | |||||||||
| Other | (1,971) | (0.9) | |||||||||
| Other foreign jurisdictions | |||||||||||
| Withholding taxes | 3,269 | 1.5 | |||||||||
| Other | 2,965 | 1.3 | |||||||||
| Effect of cross-border tax laws: | |||||||||||
| Subpart F income | 17,618 | 7.9 | |||||||||
| Other | 106 | 0.0 | |||||||||
| Tax credits: | |||||||||||
| Research and development tax credits | (41,761) | (18.6) | |||||||||
| Changes in valuation allowances | 50,891 | 22.7 | |||||||||
| Non-taxable or non-deductible items: | |||||||||||
| Stock-based compensation expense | (46,806) | (20.9) | |||||||||
| Other adjustments | 2,896 | 1.3 | |||||||||
| Changes in unrecognized tax benefits | 1,727 | 0.8 | |||||||||
| Other | 725 | 0.3 | |||||||||
| Total tax provision and effective tax rate | $ | 36,103 | 16.1 | % | |||||||
Fiscal Year Ended 2026 | |||||
| State and local | $ | 4,439 | |||
| Foreign: | |||||
| Ireland | 7,097 | ||||
| India | 6,350 | ||||
| United Kingdom | 3,095 | ||||
| Brazil | 2,602 | ||||
| Other | 8,936 | ||||
| Total | $ | 32,519 | |||
| At the End of Fiscal | |||||||||||
| 2025 | 2026 | ||||||||||
| Deferred tax assets: | |||||||||||
| Net operating loss carryforwards | $ | 32,227 | $ | 122,115 | |||||||
| Tax credit carryover | 248,502 | 334,957 | |||||||||
| Accruals and reserves | 34,259 | 40,766 | |||||||||
| Deferred revenue | 110,176 | 113,005 | |||||||||
| Stock-based compensation expense | 19,067 | 20,700 | |||||||||
| ASC 842 lease liabilities | 42,375 | 51,598 | |||||||||
| Capitalized research and development | 430,114 | 373,906 | |||||||||
| Other | 3,240 | 4,188 | |||||||||
| Total deferred tax assets | $ | 919,960 | $ | 1,061,235 | |||||||
| Valuation allowance | (755,509) | (837,625) | |||||||||
| Total deferred tax assets, net of valuation allowance | $ | 164,451 | $ | 223,610 | |||||||
| Deferred tax liabilities: | |||||||||||
| Depreciation and amortization | $ | (62,494) | $ | (97,158) | |||||||
| Deferred commissions | (70,219) | (89,323) | |||||||||
| ASC 842 right-of-use assets | (39,552) | (44,137) | |||||||||
| Interest income | (13,423) | (22,085) | |||||||||
| Total deferred tax liabilities | $ | (185,688) | $ | (252,703) | |||||||
| Net deferred tax liabilities | $ | (21,237) | $ | (29,093) | |||||||
| Fiscal Year Ended | |||||||||||||||||
| 2024 | 2025 | 2026 | |||||||||||||||
| Gross unrecognized tax benefits—beginning balance | $ | 68,897 | $ | 82,115 | $ | 101,390 | |||||||||||
| Decreases related to tax positions taken during prior years | (274) | (1,597) | (5,853) | ||||||||||||||
| Increases related to tax positions taken during prior years | — | 3,193 | — | ||||||||||||||
Decreases related to tax positions taken during current year | (16) | — | — | ||||||||||||||
Increases related to tax positions taken during current year | 13,508 | 17,679 | 20,624 | ||||||||||||||
| Gross unrecognized tax benefits—ending balance | $ | 82,115 | $ | 101,390 | $ | 116,161 | |||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2026 | Mar 25, 2026 | Showing above |
| 2025 | Mar 27, 2025 | |
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.